Home » Ravulizumab and eculizumab reduce transfusions in adult patients with paroxysmal nocturnal hemoglobinuria: evidence from three real-world databases: TriNetX us EMR, TriNetX US claims and Komodo Health
Ravulizumab and eculizumab reduce transfusions in adult patients with paroxysmal nocturnal hemoglobinuria: evidence from three real-world databases: TriNetX us EMR, TriNetX US claims and Komodo Health - TriNetX
Ravulizumab and eculizumab reduce transfusions in adult patients with paroxysmal nocturnal hemoglobinuria: evidence from three real-world databases: TriNetX us EMR, TriNetX US claims and Komodo Health
